Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123489242 | 12348924 | 2 | F | 20150819 | 20160728 | 20160509 | 20160805 | EXP | DK-ELI_LILLY_AND_COMPANY-DK201604010660 | ELI LILLY AND CO | 44.20 | YR | F | Y | 54.00000 | KG | 20160805 | MD | DK | DK |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123489242 | 12348924 | 1 | PS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 30 MG, QD | 21427 | 30 | MG | CAPSULE | QD | ||||||
123489242 | 12348924 | 2 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | UNK, UNKNOWN | 21427 | 30 | MG | CAPSULE | |||||||
123489242 | 12348924 | 3 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | UNK, UNKNOWN | 21427 | CAPSULE |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123489242 | 12348924 | 1 | Fibromyalgia |
123489242 | 12348924 | 2 | Depression |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
123489242 | 12348924 | OT |
123489242 | 12348924 | DS |
123489242 | 12348924 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123489242 | 12348924 | Activities of daily living impaired | |
123489242 | 12348924 | Anxiety | |
123489242 | 12348924 | Blood cholesterol increased | |
123489242 | 12348924 | Blood prolactin increased | |
123489242 | 12348924 | Cerebral disorder | |
123489242 | 12348924 | Decreased appetite | |
123489242 | 12348924 | Dizziness | |
123489242 | 12348924 | Drug withdrawal convulsions | |
123489242 | 12348924 | Drug withdrawal syndrome | |
123489242 | 12348924 | Fear | |
123489242 | 12348924 | Headache | |
123489242 | 12348924 | Heart rate increased | |
123489242 | 12348924 | Hemiplegia | |
123489242 | 12348924 | Hypertension | |
123489242 | 12348924 | Hypohidrosis | |
123489242 | 12348924 | Insomnia | |
123489242 | 12348924 | Malaise | |
123489242 | 12348924 | Micturition urgency | |
123489242 | 12348924 | Nausea | |
123489242 | 12348924 | Neoplasm | |
123489242 | 12348924 | Off label use | |
123489242 | 12348924 | Palpitations | |
123489242 | 12348924 | Panic disorder | |
123489242 | 12348924 | Paraesthesia | |
123489242 | 12348924 | Postmenopausal haemorrhage | |
123489242 | 12348924 | Speech disorder | |
123489242 | 12348924 | Ulcer haemorrhage | |
123489242 | 12348924 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
123489242 | 12348924 | 1 | 20090401 | 20150819 | 0 |